Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Could a simple blood test predict Sjögren's severity?

NCT ID NCT07414667

Summary

This study aims to understand if measuring levels of a specific antibody (anti-Ro52) in the blood can help predict how Sjögren's syndrome will progress. Researchers will follow 150 patients with primary Sjögren's syndrome to see if higher antibody levels are linked to more severe symptoms or complications. The goal is to determine if this measurement could help doctors better monitor and manage the disease.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SJÖGREN´S SYNDROME are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Université de Nancy

    Vandœuvre-lès-Nancy, 54500, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.